Unknown

Dataset Information

0

European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial Fibrillation.


ABSTRACT: This study compared the risk of mortality in atrial fibrillation (AF) patients treated adherent to the 2012 European Society of Cardiology (ESC) guidelines for stroke prevention and those who were not treated according to guideline recommendations. This study used the Taiwan National Health Insurance Research Database. From 1996 to 2011, 354,649 newly diagnosed AF patients were identified as the study population. Among the study cohort, 45,595 and 309,054 patients were defined as Guideline-Adherent and Non-Adherent groups, respectively. During the follow up of 1,480,280 person-years, 133,552 (37.7%) patients experienced mortality. The risk of mortality was lower among AF patients whose treatment was adherent to the guideline recommendation for stroke prevention than those whose treatment was not (annual risk of mortality?=?4.3% versus 10.0%) with an adjusted hazard ratio of 0.62 (95% confidence interval?=?0.61-0.64, p value?

SUBMITTER: Li CH 

PROVIDER: S-EPMC4976390 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial Fibrillation.

Li Cheng-Hung CH   Liu Chia-Jen CJ   Chou Annie Y AY   Chao Tze-Fan TF   Tuan Ta-Chuan TC   Chen Su-Jung SJ   Wang Kang-Ling KL   Lin Yenn-Jiang YJ   Chang Shih-Lin SL   Lo Li-Wei LW   Hu Yu-Feng YF   Chung Fa-Po FP   Liao Jo-Nan JN   Chen Tzeng-Ji TJ   Wu Tsu-Juey TJ   Chen Shih-Ann SA  

Scientific reports 20160808


This study compared the risk of mortality in atrial fibrillation (AF) patients treated adherent to the 2012 European Society of Cardiology (ESC) guidelines for stroke prevention and those who were not treated according to guideline recommendations. This study used the Taiwan National Health Insurance Research Database. From 1996 to 2011, 354,649 newly diagnosed AF patients were identified as the study population. Among the study cohort, 45,595 and 309,054 patients were defined as Guideline-Adher  ...[more]

Similar Datasets

| S-EPMC5047003 | biostudies-other
| S-EPMC5642160 | biostudies-literature
| S-EPMC3875245 | biostudies-literature
| S-EPMC1860779 | biostudies-literature